ARDX-Ardelyx

[ddriscoll9]

After the recent write-up on Value Investors Club on Ardelyx, I became interested in this stock. The thesis seems simple enough (less pills, less side effects); however, I am new to Biotech investing and I am aware it is outside my circle of competence. Could anyone shed light on how likely it is for this drug to be approved by the FDA and commercialized? I am aware it has been approved by the FDA in 2019 by only for IBS. 

 

I have also read the recent write up on VIC on KPTI and am interested on anyone’s thoughts.